Do you want to read an article? Please log in or register.
Effect of Fremanezumab Monthly and Quarterly Doses on Efficacy Responses
Migraine and Headache
RECOMMENDED
Related content
RECOMMENDED
Migraine and Headache
No 'Wearing-off Effect' Seen in Quarterly or Monthly Dosing of Fremanezumab: Sub-analysis of a Randomized Long-term Study
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Headache
Blumenfeld AM, Stevanovic DM, Ortega M, Cohen JM, Seminerio MJ, Yang R, Jiang B, Tepper SJ
doi: 10.1111/head.13994
Migraine and HeadacheAnxiety and Depression
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial
JAMA.
Dodick DW, Silberstein SD, Bigal ME, Yeung PP, Goadsby PJ, Blankenbiller T, Grozinski-Wolff M, Yang R, Ma Y, Aycardi E
Migraine and Headache
Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine
Headache.
Winner PK, Spierings ELH, Yeung PP, Aycardi E, Blankenbiller T, Grozinski-Wolff M, Yang R, Ma Y
doi: 10.1111/head.13654.
SPECIAL REPORT
Multiple Sclerosis
Vaccination Readiness in Multiple Sclerosis
Migraine and HeadacheAnxiety and Depression
Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study
Headache
Lipton RB, Cohen JM, Galic M, Seminerio MJ, Yeung PP, Aycardi E, Bigal ME, Bibeau K, Buse DC
doi: 10.1111/head.14097
Migraine and Headache
Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate response to 2 to 4 classes of migraine-preventive medications in the phase 3b FOCUS study
Headache
Spierings ELH, Ning X, Ramirez Campos V, Cohen JM, Barash S, Buse DC
doi: 10.1111/head.14196
Migraine and Headache
Effects of fremanezumab on the use of acute headache medication and associated symptoms of migraine in patients with episodic migraine
Cephalalgia.
Brandes JL, Kudrow D, Yeung PP, Sakai F, Aycardi E, Blankenbiller T, Grozinski-Wolff M, Yang R, Ma Y
doi: 10.1177/0333102419885905.
Further Publications NeurologyFurther Publications Psychiatry
Efficacy and cost-effectiveness of an adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy: a pragmatic, open-label, randomised controlled trial
Lancet Psychiatry.
Marsden J, Stillwell G, James K, Shearer J, Byford S, Hellier J, Kelleher M, Kelly J, Murphy C, Mitcheson L
doi: 10.1016/S2215-0366(19)30097-5.
Migraine and Headache
Dose selection for fremanezumab (AJOVY) phase 3 pediatric migraine studies using pharmacokinetic data from a pediatric phase 1 study and a population pharmacokinetic modeling and simulation approach
Cephalalgia
Cohen-Barak O, Radivojevic A, Jones A, Fiedler-Kelly J, Gillespie M, Brennan M, Gutman D, Rasamoelisolo M, Hallak H, Loupe P, Kessler Y, Ning X, Levi M, Ahn AH, Rabinovich-Guilatt L
doi: 10.1177/03331024211007789